High Patient, Physician Satisfaction With Pharmacy-Led Monitoring Program for Oral Antineoplastic Agents

April 16, 2021 09:21pm

Research presented at the HOPA Annual Conference 2021 supported the benefit and feasibility of a pharmacy-led adherence and monitoring program for oral antineoplastic agents.

Coronavirus News Roundup: Pharmacists Can Improve Vaccine Uptake; FDA and CDC Recommend Pause for Johnson & Johnson Vaccine
Become That Someone for Your Patients
FDA OKs New Combined Oral Contraceptive
Understanding Specialty Pharmacy (Part 1)